Role of xanthine oxidase in conduit artery endothelial dysfunction in cigarette smokers
- 1 March 2004
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 93 (5), 664-668
- https://doi.org/10.1016/j.amjcard.2003.11.046
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Xanthine Oxidase–Derived Reactive Oxygen Species Convert Flow-Induced Arteriolar Dilation to Constriction in HyperhomocysteinemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Serum Uric Acid and Cardiovascular MortalityJAMA, 2000
- Nitrosation of Uric Acid by PeroxynitritePublished by Elsevier BV ,1998
- Xanthine Oxidase Inhibition With Oxypurinol Improves Endothelial Vasodilator Function in Hypercholesterolemic but Not in Hypertensive PatientsHypertension, 1997
- Antioxidant Vitamin C Improves Endothelial Dysfunction in Chronic SmokersCirculation, 1996
- Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjectsBritish Journal of Clinical Pharmacology, 1996
- Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.Circulation, 1993
- Uric acid as radical scavenger and antioxidant in the heartPflügers Archiv - European Journal of Physiology, 1989
- Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.British Journal of Clinical Pharmacology, 1988
- Clinical Pharmacokinetics of AllopurinolClinical Pharmacokinetics, 1986